A Prospective Study of Conventional and Expanded Coagulation Indices in Predicting Ulcer Bleeding After Variceal Band Ligation

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 9, 2009, Pages 988-993

  Vieira da Rocha, Evandra Cristina ^a   D'Amico, Elbio Antonio ^a   Caldwell, Stephen Hugh ^b   Flores da Rocha, Tania Rubia ^a   Soares E Silva, Cristina Simões Solon ^a   Dos Santos Bomfim, Valdinelia ^a   Felga, Guilherme ^a   Barbosa, Walnei Fernandes ^a   Kassab, Fabio ^a   Polli, Demerson Andre ^a   Carrilho, Flair Jose ^a   Farias, Alberto Queiroz ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; D DIMER; FIBRINOGEN; PROPRANOLOL; PROTEIN C; PROTEIN S; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING TEST; DEVICE; ESOPHAGEUS VARICES BAND LIGATION; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIGATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PEPTIC ULCER BLEEDING; PORTAL HYPERTENSION; PROGNOSIS; PROSPECTIVE STUDY; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTICOAGULANTS; COMBINED MODALITY THERAPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIGATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 69249229470     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.04.019     Document Type: Article

References (31)

1. D'Amico G., Pagliaro L., and Bosch J. Treatment of portal hypertension: a meta-analytic review. Hepatology 22 (1995) 332-354
2. D'Amico G., De Franchis R., and Cooperative Study Group. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
3. Bosch J., Thabut D., Bendtsen F., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
4. De Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
5. Garcia-Tsao G., Bosch J., and Groszmann R.J. Portal hypertension and variceal bleeding-unresolved issues: summary of an American Association for the study of liver disease and European Association for the study of the liver single-topic conference. Hepatology 47 (2008) 1764-1772
6. Imperiale T.F., and Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 33 (2001) 802-807
7. Norberto L., Polese L., Cillo U., et al. A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl 13 (2007) 1272-1278
8. Tripodi A., Caldwell S.H., Hoffman M., et al. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther 26 (2007) 141-148
9. Tripodi A., and Mannucci P.M. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 46 (2007) 727-733
10. Caldwell S.H., Hoffman M., Lisman T., et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 44 (2006) 1039-1046
11. Lisman T., Leebeek F.W., and de Groot P.G. Haemostatic abnormalities in patients with liver disease. J Hepatol 37 (2002) 280-287
12. Lisman T., Bongers T.N., Adelmeijer J., et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 44 (2006) 53-61
13. Ferro D., Quintarelli C., Lattuada A., et al. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Hepatology 23 (1996) 1377-1383
14. Tripodi A., Salerno F., Chantarangkul V., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41 (2005) 553-558
15. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
16. Llovet J., Brú C., and Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
17. WHO Expert Committee on Biological Standardization. World Health Organ Tech Rep Ser 889 (1999) 1-111
18. Montalto P., Vlachogiannakos J., Cox D.J., et al. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 37 (2002) 463-470
19. Marti-Carvajal A.J., Salanti G., and Marti-Carvajal P.I. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver disease. Cochrane Database Syst Rev (2007) CD004887
20. Tripodi A., Primignani M., Chantarangkul V., et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 44 (2006) 440-445
21. Mannucci P.M., Canciani M.T., Forza I., et al. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 98 (2001) 2730-2735
22. Spadaro A., Tortorella V., Morace C., et al. High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. World J Gastroenterol 14 (2008) 1549-1552
23. Salooja N., and Perry D.J. Thromboelastography. Blood Coagul Fibrinolysis 12 (2001) 327-337
24. Hu K.Q., Yu A.S., Tiyyagura L., et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 96 (2001) 1581-1586
25. Yang M.T., Chen H.S., Lee H.C., et al. Risk factors and survival of early bleeding after esophageal variceal ligation. Hepatogastroenterology 54 (2007) 1705-1709
26. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 319 (1988) 983-989
27. Wadhawan M., Dubey S., Sharma B.C., et al. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites and Child's status. Dig Dis Sci 51 (2006) 2264-2269
28. Adams M., Ward C., Thom J., et al. Emerging technologies in hemostasis diagnostics: a report from the Australasian Society of Thrombosis and Haemostasis Emerging Technologies Group. Semin Thromb Hemost 33 (2007) 226-234
29. Favaloro E.J. Investigating people with mucocutaneous bleeding suggestive of primary hemostatic defects: a low likelihood of a definitive diagnosis?. Haematologica 92 (2007) 292-296
30. Bellest L., Eschwège V., Poupon R., et al. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. A. Hepatology 46 (2007) 528-534
31. Tripodi A., Chantarangkul V., Primignani M., et al. The international normalized ratio calibrated for cirrhosis (INR-liver) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 46 (2007) 520-527